Larynx preservation

Current Opinion in Oncology

Volumn 24, Issue 3, 2012, Pages 218-222

  Lefebvre, Jean Louis ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

chemotherapy; larynx preservation; radiotherapy; surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; FLUOROURACIL;

CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMORADIOTHERAPY; DECISION MAKING; HUMAN; HYPOPHARYNX CANCER; LARYNGECTOMY; LARYNX CANCER; LARYNX PRESERVATION; LARYNX SURGERY; ORGAN PRESERVATION; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LARYNX; MALE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION;

EID: 84859875654     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0b013e3283523c95     Document Type: Review

References (32)

1. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991; 324:1685-1690.
2. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996; 88:890-899. (Pubitemid 26230640)
3. Richard JM, Sancho-Garnier H, Pessey JJ, et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 1998; 34:224-228. (Pubitemid 28267175)
4. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349:2091-2098. (Pubitemid 37464533)
5. Pointreau Y, Garaud P, Chapet S, et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 2009; 101:498-506.
6. Lefebvre JL, Rolland F, Tesselaar M, et al. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 2009; 101:142-152.
7. Lefebvre JL, Pointreau Y, Rolland F, et al. Sequential chemoradiotherapy (SCRT) for larynx preservation (LP): preliminary results of the randomized phase II TREMPLIN study. J Clin Oncol 2011; 360s(Suppl):abstr 5501.
8. Lefebvre JL, Ang KK. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary. Int J Radiat Oncol Biol Phys 2009; 73:1293-1303.
9. Lefebvre JL, Ang KK. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary. Head Neck 2009; 31:429-441.
10. Ang KK. Larynx preservation clinical trial design: summary of key recommendations of a consensus panel. Oncologist 2010; 15:25-29.
11. Silver CE, Beitler JJ, Shaha AR, et al. Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otolaryngol 2009; 266:1333-1352.
12. Sanabria A, Domenge C, D'Cruz A, Kowalski LP. Organ preservation protocols in developing countries. Curr Opin Otolaryngol Head Neck Surg 2010; 18:83-88.
13. Hartl DM, Ferlito A, Brasnu DF, et al. Evidence-based review of treatment options for patients with glottis cancer. Head Neck 2011; 33:1638-1648.
14. Corry J, Rischin D, Cotton S, et al. Larynx preservation with primary nonsurgical treatment for loco-regionally advanced larynx cancer. J Med Imaging Radiat Oncol 2011; 55:229-235.
15. Olsen KD. Reexamining the treatment of advanced laryngeal cancer. Head Neck 2010; 32:1-7.
16. Wolf GT. Reexamining the treatment of advanced laryngeal cancer: the VA larynx cancer study revisited. Head Neck 2010; 32:7-14.
17. Forastiere AA. Larynx preservation and survival trends: should there be concern? Head Neck 2010; 32:14-17.
18. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the US: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116 (Suppl 111):1-13. (Pubitemid 44337830)
19. Chen AY, Fedewa S, Zhu J. Temporal trends in the treatment of earlyand advanced-stage laryngeal cancer in the United States, 1985-2007. Arch Otolaryngol Head Neck Surg 2011; 137:1017-1024.
20. Suarez C, Rodrigo JP, Silver CE, et al. Laser surgery for early to moderately advanced glottis, supraglottic, and hypopharyngeal cancers. Head Neck 2011. doi: 10.1002/hed.21770.
21. Vilaseca I, Bernal-Sprekelsen M, Blanch JL. Transoral laser microsurgery for T3 laryngeal tumors: prognostic factors. Head Neck 2010; 32:929-938.
22. Castro A, Sanchez-Cuadrado I, Bernaldez R, et al. Larynx function preservation following supracricoid partial laryngectomy. Head Neck 2012; 34:162-167.
23. Holsinger FC, Kies MS, Diaz EM Jr, et al. Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol 2009; 27:1976-1982.
24. Posner MR, Norris CM, Wirth LJ, et al. Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 2009; 20:921-927.
25. Dietz A, Rudat V, Dreyhaupt J, et al. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur Arch Otolaryngol 2009; 266:1291-1300.
26. Kawashima M, Hayashi R, Tahara M, et al. Prospective trial of chemotherapyenhanced accelerated radiotherapy for larynx preservation in patients with intermediate-volume hypopharyngeal cancer. Head Neck 2011. doi: 10.1002:hed.21934.
27. Liu WS, Hsin CH, Chou YH, et al. Long-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservation. BMC Cancer 2010; 10:102.
28. Rades D, Schroeder U, Bajrovic A, Schild SE. Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer-results of a matched-pair analysis. Eur J Cancer 2011; 47:2729-2734.
29. Patel UA, Howell LK. Local response to chemoradiation in T4 larynx cancer with cartilage invasion. Laryngoscope 2011; 121:106-110.
30. Miah AB, Bhide SA, Guerrero-Urbano MT, et al. Dose-escalated intensitymodulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 2011; 82:539-547.
31. Bosetti C, Bertuccio P, Levi F, et al. Cancer mortality in European Union, 1970-2003, with a jointpoint analysis. Ann Oncol 2008; 19:631-640. (Pubitemid 351461031)
32. Horn S, Ozsahim M, Lefebvre JL, et al. Larynx preservation: what is the standard treatment? Crit Rev Oncol/Hematol 2011. doi: 10.1016/j.critrevonc. 2010.11.008.